Day 1Monday, March 8, 2027

Eliminating cancer return with nanomedicine: Human clinical trials
Thomas J. Webster, Brown University, United StatesThis presentation will cover a close to 30 year journey researching and commercializing nanotechnology for improving disease prevention, diagnosis, and treatment (including cancer) which has led to numerous products including nano spinal implants now in over 45,000 patients to date showing no signs…
View Full Abstract →
Anemia management in the context of ESAs and transfusions within oncology and hematology
Franco Musio, University of Virginia School of Medicine, United StatesTo be updated shortly..!!
View Full Abstract →
Artificial radionuclides and evolutionary mismatch: Vulnerability of the colon, pancreas, diabetes, and arteries
Venturi Sebastiano, Department of Public Health of Rimini, ItalyThe global dissemination of artificial radionuclides since 1945 represents a novel environmental condition in evolutionary terms. Isotopes such as Cesium-137 (Cs-137) and Iodine-131 (I-131), generated through nuclear weapons testing, reactor accidents, and nuclear energy production, were not…
View Full Abstract →
Personalized and precision medicine (PPM) through the view of bio design-inspired translational research: An option for clinical oncologists, caregivers and consumers to realize the potential of genomics-informed care to secure the human biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, RussiaA new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, personalized and precision medicine (PPM). Meanwhile, the era of genomics-based medicine and thus genomics biomarkers promises to provide molecular tests that will permit PPM as…
View Full Abstract →
Mitochondria and malignant neoplasms: the impact of mtdna variations on carcinogenesis
Ludmila Grzybowska Szatkowska, Medical University of Lublin, PolandMitochondria play a crucial role in cellular oxidation and eukaryotic cell function, possessing their own genome (mtDNA) that encodes polypeptides of the respiratory chain complexes. While the pathogenesis of neoplasms is highly complex, the role of mtDNA alterations in carcinogenesis remains…
View Full Abstract →
Personalized and precision oncology (PPO) via upgraded cancer design strategy for cancer care team: Developing targeted cancer therapy & advancing personalized cancer care
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, RussiaA new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, personalized and precision medicine (PPM). The concept of PPM is becoming increasingly relevant for cancer treatment, moving from the ‘one-size-fits-all’ standard therapy to a more…
View Full Abstract →
A Modular Synthetic DNA Template Platform for Rapid Generation of TCR-Encoding mRNA and Streamlined Validation of Cognate TCR-Epitope Reactivity
Lorenzo Franceschini, VUB Health campus, Brussels, BelgiumThe interaction between T-cell receptors (TCRs) and their cognate ligands plays an important role in the regulation of the adaptive immune system as this is key in inducing immune responses in cancer, infectious and autoimmune diseases. As identification of a cognate TCR relies on laborious…
View Full Abstract →
Stages at diagnosis and barriers to early diagnosis of head and neck cancers in a low income setting: A 6 year retrospective study at the douala general hospital and the cameroon oncology center
Mbella Irene Ewelisane, University of Buea, CameroonHead and neck cancers (HNCs) are an increasing public health concern, particularly in low- and middle-income countries such as Cameroon. They affect vital anatomical sites, including the oral cavity, pharynx, larynx, nasal cavity, paranasal sinuses, and salivary glands. In Cameroon, the burden is…
View Full Abstract →
Sex based clinicopathological characteristics and survival of balloon cell melanoma: a population based seer analysis
Rahul Hajare, Sandip University, IndiaBalloon Cell Melanoma is an uncommon type of melanoma with insufficient population-level epidemiological data. The objective of this study is to examine the incidence rate, clinicopathological features, survival outcomes, and gender differences in patients diagnosed with BCM based on SEER-18…
View Full Abstract →
World program against cancer in low and middle incomes countries
El Hadji Seydou Mbaye, International Agency for Research on Cancer Dakar, SenegalINTRODUCTION: Worldwide, one in eight deaths is due to cancer. Projections based on the GLOBOCAN 2012 estimates predict a substantive increase new cancer cases per year by 2035 in developing countries if preventive measures are not widely applied. According to the World Health Organization (WHO),…
View Full Abstract →
Surgical management of primary malignant chest wall tumors: Case series
Wissal Rouabeh, Sahloul University Hospital, TunisiaBackground: Primary malignant tumors of the chest wall are rare, accounting for approximately 5% of all thoracic tumors. Their prognosis depends mainly on histological subtype and completeness of surgical resection, and management often requires complex reconstruction to preserve chest wall…
View Full Abstract →
Recurrent right sided cardiac synovial sarcoma in a 12-year-old adolescent: A rare case and review of the literature
Wissal Rouabeh, Sahloul University Hospital, TunisiaBackground: Primary cardiac synovial sarcoma (CSS) is an exceptionally rare and aggressively malignant tumor, particularly in the pediatric population, where nonspecific manifestations often lead to delayed or misdiagnosis. Case Summary: We report the case of a 12-year-old boy who presented with…
View Full Abstract →
Strengthening primary healthcare clinics to reduce delays in cancer care: findings from kenya
Franklin Kiplagat Koech, African Population and Health Research Center(APHRC), KenyaBackground: Delays in cancer care contribute to poor outcomes in Sub-Saharan Africa, including Kiambu County, Kenya. These delays occur at multiple levels, including late presentation, delayed diagnosis, inefficient referrals, and limited treatment readiness at primary healthcare facilities.…
View Full Abstract →
Drug-induced oral toxicity with severe stomatitis and treatment modifications under trop-2-targeted antibody–drug conjugates in advanced solid tumors: A systematic review and meta-analysis
Inshall Nadeem, Bahria University Health Sciences Campus, PakistanBackground: Trophoblast cell-surface antigen 2 (TROP-2)-directed antibody–drug conjugates (ADCs) have transformed the treatment landscape of advanced solid tumors. However, stomatitis and oral mucositis represent major dose-limiting toxicities. We synthesized evidence from randomized controlled…
View Full Abstract →
The significance of diffusion-tensor imaging (DTI) and how it can help with effective treatments for brain metastases patients
Adam Khanboubi, Dana Farber Cancer Institute, United StatesBrain metastases represent a significant challenge in cancer care, affecting approximately 150,000 to 200,000 individuals annually. Among patients with stage 4 breast cancer, an estimated 10–15% develop metastatic tumors in the brain, often requiring surgical intervention. While conventional…
View Full Abstract →
Stage-specific multimodal rehabilitation after breast cancer treatment: Prospective evidence across treatment-related complications
Liliya, N.N.Petrov of MoH of Russia, RussiaObjective : To evaluate the efficacy and safety of stage-specific multimodal rehabilitation incorporating physical therapy modalities after multimodal breast cancer (BC) treatment. Methods : Four prospective cohorts included 250 patients. At 2–4 weeks after surgery, 73 patients received therapeutic…
View Full Abstract →
MEK1 mediate 3D specific chemoresistance to etoposide revealed by a CRISPR screen in tumor spheroids
DU Chengyue, Hong Kong Baptist University, Hong Kong, ChinaBackground & Objective :Chemoresistance remains the foremost impediment to curative cancer therapy, yet its mechanistic dissection is often confounded by the reductionist nature of conventional 2D cell culture, which fails to recapitulate the architectural, hypoxic, and matrix-mediated cues of…
View Full Abstract →
Artificial intelligence-driven biomarker discovery in brain cancer: an integrative computational approach
Sarita Maurya, University of Allahabad, IndiaBrain cancer represents a major challenge in oncology because of its molecular heterogeneity, complex disease mechanisms, and variability in patient responses to treatment. Identification of reliable molecular biomarkers can support improved disease characterization, diagnosis, prognosis, and…
View Full Abstract →
Impact of normalization strategies on the diagnostic performance of salivary microRNAs for early detection of oral squamous cell carcinoma: A systematic review, diagnostic meta-analysis, and meta-regression
Jamal Khan, Khyber College of Dentistry, PakistanSalivary microRNAs (miRNAs) are promising non-invasive biomarkers for the early detection of oral squamous cell carcinoma (OSCC), but variability in normalization strategies limits their reproducibility and clinical translation. This PRISMA-guided systematic review (PROSPERO: CRD420261465738)…
View Full Abstract →
Matrix metalloproteinase [MMP]-2 (2735C>T) and tissue inhibitor of metalloproteinase [TIMP]-2 (2418G>C) genetic variants as predictors of human papillomavirus-mediated cervical cancer amongst women of asian indian ethnicity: Immuno-oncology snapshot
Saumya Pandey, IndiraIVF Hospital, IndiaObjectives: Inflammation is a hallmark of HPV-mediated cervical cancer; Matrix metalloproteinase [MMP]-2 and tissue inhibitor of metalloproteinase [TIMP]-2 are emerging as pivotal players in inflammation and carcinogenesis. My study aimed to evaluate the role of MMP-2 (-735C>T) [rs2285053] and…
View Full Abstract →
CTCF-mediated epigenetic control of T helper cell differentiation in non-small cell lung cancer
Koustav Sarkar, SRM Institute of Science and Technology, IndiaNon-small-cell-Lung-Cancer (NSCLC) remains a chief global health concern despite medical advancements. This study investigates the pivotal role of CCCTC-binding factor (CTCF), an 11-zinc finger protein acting as a transcription factor, in NSCLC progression. It can work either as a transcriptional…
View Full Abstract →
Adding immune checkpoint inhibitors to locoregional therapy for unresectable intermediate-to-advanced hepatocellular carcinoma: A systematic review and network meta-analysis
Rayan Saleh Alsaud, Qassim University, Saudi ArabiaBackground: Locoregional therapy (LRT) is the main treatment for unresectable intermediate-to-advanced hepatocellular carcinoma (HCC), but survival remains poor. Immune checkpoint inhibitors (ICIs) are now standard systemic therapy for advanced HCC. LRT can release tumour antigens and alter the…
View Full Abstract →
Identification of HER2 status in patients with invasive breast carcinoma at a tertiary care centre in sri lanka: A clinical audit
Dilshani Kaushalya Abeygunawardhana, National Hospital Galle, Sri LankaIntroduction and objective:Molecular subtyping of invasive breast carcinomas (IBC) is crucial for patient management, predicting clinical outcome and prognostication. HER2 overexpression is seen in approximately 15–25% of IBC, which have worse prognosis than luminal tumours and require targeted…
View Full Abstract →
From lived experience to community advocacy: The role of cancer & vie in promoting awareness, peer support and patient navigation in senegal
Ngone Gaye, Cancer & Vie, SenegalBackground: Cancer affects more than physical health. It can also create emotional, social and informational challenges for patients and their families. Drawing on my experience as a cervical cancer survivor in Senegal, I founded Cancer & Vie, an independent digital initiative intended to promote…
View Full Abstract →
Factors associated with late-stage cancer diagnosis in kiambu county, kenya: apopulation-based cancer registry analysis, 2022–2025
Kelvin Opiyo Onyango, National cancer institute of kenya, KenyaBackground : Behind every registry record is a person whose stage at diagnosis shapes the treatment they can reach,the care their family must provide and their chance of long-term survival. In sub-Saharan Africa, late presentationremains a major barrier to cancer control, yet population-based…
View Full Abstract →
Where women are lost between screening and treatment: same-day screen-and-treat versus deferred treatment in community cervical cancer screening outreach in kenya
Linet Koskei, National cancer institute of kenya, KenyaBackground : Every woman with cervical precancer is one treatment away from never developing cancer, and everymissed treatment leaves a preventable cancer to chance. Yet in 2024 only 43% of treatment-eligible women inKenya received treatment (Ministry of Health, Kenya, 2025), against the WHO…
View Full Abstract →
Sensitivity analysis of environmental and positional parameters in HDR Ir-192 source calibration
Asif Rauf, Shaukat Khanum Memorial Cancer Hospital, PakistanIntroduction : Accurate calibration of high-dose-rate (HDR) Iridium-192 (Ir-192) sources is essential for ensuring dosimetric accuracy and treatment safety in brachytherapy. Environmental and procedural factors, including temperature, atmospheric pressure, source positioning, and decay timing, may…
View Full Abstract →
Day 2Tuesday, March 9, 2027

Purpura fulminans beyond sepsis: a paraneoplastic presentation of diffuse large B-cell lymphoma
Emily Finn, Royal Devon and Exeter University Healthcare NHS Foundation Trust, United KingdomBackground: Purpura fulminans is a rare, life threatening thrombotic disorder characterised by rapidly progressive cutaneous microvascular thrombosis, haemorrhagic infarction, and skin necrosis. It is classically associated with overwhelming bacterial sepsis,particularly Neisseria meningitidis, but…
View Full Abstract →
A tour towards discovery of novel PIM-1 kinase inhibitors through a machine learning and molecular modelling approach
Vinayak S. Walhekar, DPGU, IndiaPro-viral integration sites for Moloney murine leukaemia virus (PIM) kinases are the members of serine/threonine kinase family, that elevate cell division and inhibit apoptosis, thus making them as an attractive anticancer target. In this study, a virtual screening strategy based on a pharmacophore…
View Full Abstract →
Spatial immunophysiology of glioblastoma: Integrative mapping of neuroimmune niches governing tumor evolution, immune escape, and resistance to precision immunotherapy
Abdulganiyyu Abdullahi Ahmad, Federal University of Agriculture, Zuru, NigeriaBackground and Objectives: Glioblastoma (GBM) is a highly aggressive, immunosuppressive neuroepithelial malignancy with a complex spatial architecture and profound resistance to immunotherapy. This study aims to integratively map neuroimmune niches within the GBM tumor microenvironment (TME) to…
View Full Abstract →
Integration of hydro kinesiotherapy in functional and neuro-cognitive recovery after mastectomy: A clinical study on 30 patients
Rachele Lazzeroni, INI Grottaferrata, ItalyMastectomy is a surgical procedure that profoundly alters tissue homeostasis and upper limb function. In the analyzed sample (n=30), the predominant etiology was invasive breast carcinoma (85%), followed by prophylactic mastectomy (15%) in BRCA1/2 mutation carriers. The removal of cutaneous and…
View Full Abstract →
Educational, scientific, and clinical management for cancer prevention in the community context
Josefa Bell Castillo, Internal medicine specialist at an eye clinic, MexicoThe research proposes the Scientific-Clinical Training Management Model for cancer prevention in the community context as a theoretical and practical contribution aimed at fostering epistemological, praxiological, and professional development.The model is grounded in dialectical categorical…
View Full Abstract →
Cancer-related cognitive impairment in survivors: Bridging neuro-oncology and community-based survivorship care in india
Medinee Deep Saxena, GMC, Amritsar, IndiaBackground: Cancer-related cognitive impairment (CRCI) affects memory, attention, processing speed and executive function. About one in three breast cancer survivors may have clinically significant impairment on neuropsychological testing, and roughly 26% of lung cancer survivors are affected.…
View Full Abstract →
Computed tomography and histopathological correlation in peutz–jeghers syndrome presenting with multilevel intussusception: A rare case report
Usama Farooq Hanjra, CH M Akram Teaching and Research Hospital, PakistanAims / Objectives:To highlight the characteristic computed tomography (CT) and histopathological findings of Peutz–Jeghers syndrome (PJS), emphasizing the role of radiological imaging in early diagnosis and management of this rare hereditary polyposis syndrome. Materials & Methods: A 26-year-old…
View Full Abstract →
Application of magnetic particle imaging in pancreatic ductal adenocarcinoma: Current evidence and future prospects - a literature review
Tsaniya Ahda Indrayani, Islamic University of Indonesia, IndonesiaBackground : Pancreatic ductal adenocarcinoma (PDAC) often late to diagnose because of conventional imaging modalities. Current CT and MRI have limited sensitivity for small or early-stage lesions, resulting in 10% survival rate. Magnetic particle imaging (MPI) is an novel modality that directly…
View Full Abstract →
Chromatin remodeling in cancer
Shahnd AbuKaresh, University of Naples Federico , ItalyChromatin remodeling is a key epigenetic process that regulates gene expression, cellular differentiation, and genome stability. Changes in chromatin structure and epigenetic regulation are increasingly recognized as significant contributors to cancer development and progression. In particular, the…
View Full Abstract →
Clonal hematopoiesis at the tumor–immune interface: How tet2- and dnmt3a-mutant myeloid cells shape antitumor immunity and immunotherapy response
Enayat Almasri, Rakmhsu, United Arab EmiratesBackground : Clonal hematopoiesis of indeterminate potential (CHIP) is an age-associated condition characterized by the expansion of hematopoietic stem-cell clones carrying somatic mutations in the absence of an established hematological malignancy. Although traditionally regarded as a risk factor…
View Full Abstract →
Day 3Wednesday, March 10, 2027
The Day 3 program will be updated shortly
We're preparing this information. Please check back soon.